About: http://hub.abes.fr/oup/periodical/brheum/2008/volume_47/issue_4/w

Documentation

scienceplus.abes.fr version Bêta

scienceplus.abes.fr | explorer

À propos de : http://hub.abes.fr/oup/periodical/brheum/2008/volume_47/issue_4/w Goto Sponge NotDistinct Permalink

Attributs	Valeurs
type	work Issue
Is Part Of	http://hub.abes.fr/oup/periodical/brheum/2008/volume_47
has manifestation of work	http://hub.abes.fr/oup/periodical/brheum/2008/volume_47/issue_4/m/print http://hub.abes.fr/oup/periodical/brheum/2008/volume_47/issue_4/m/web
Date Copyrighted	2007 2008
Rights	© The Author 2007. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org © 2008 The Author(s) © Published by Oxford University Press on behalf of the British Society for Rheumatology 2007. © The Author 2008. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
issue	4
Access Rights	creative-commons
is Is Part Of of	Anti-arthritic effects of combined treatment with histone deacetylase inhibitor and low-intensity ultrasound in the presence of microbubbles in human rheumatoid synovial cells Comment on: An allograft inflammatory factor 1 (AIF1) single nucleotide polymorphism (SNP) is associated with anticentromere antibody positive systemic sclerosis Effects of advanced glycation end products on the expression of COX-2, PGE2 and NO in human osteoarthritic chondrocytes Mouse model of dermal fibrosis induced by one-time injection of bleomycin-poly(l-lactic acid) microspheres Clinical identification and treatment of a rapidly progressing disease state in patients with rheumatoid arthritis Leptin and ANCA-associated vasculitis: a healthy link? Low-intensity pulsed ultrasound for chronic patellar tendinopathy: a randomized, double-blind, placebo-controlled trial Comment on: Delay in presentation to primary care physicians is the main reason why patients with rheumatoid arthritis are seen late by rheumatologists Conservative management for tendinopathy: is there enough scientific evidence? Assessment of an infectious disease history preceding juvenile dermatomyositis symptom onset Role of imaging studies in the diagnosis and follow-up of large-vessel vasculitis: an update Comment on: Delay in presentation to primary care physicians is the main reason why patients with rheumatoid arthritis are seen late by rheumatologists: reply Recent advances in the genetics of RA susceptibility Cost-effectiveness of abatacept in patients with moderately to severely active rheumatoid arthritis and inadequate response to methotrexate Association of Kikuchi-Fujimoto's disease with SLE Comment on: The candidate lupus susceptibility gene Ifi202a is largely dispensable for B-cell function: reply Reduced folate carrier polymorphism determines methotrexate uptake by B cells and CD4+ T cells MAPKs and their relevance to arthritis and inflammation The relation between composite ultrasound measures and the DAS28 score, its components and acute phase markers in adult RA Disease Activity Score 28-ESR bears a similar relationship to treatment decisions across different rheumatologists, but misclassification is too frequent to replace physician judgement Genetic variation in proteins of the cryopyrin inflammasome influences susceptibility and severity of rheumatoid arthritis (The Swedish TIRA project) Decrease of RA-related orthopaedic surgery of the upper limbs between 1998 and 2004: data from 54 579 Swedish RA inpatients Pseudoneuropathic CPPD arthropathy: magnesium matters Shared familial risk factors between cancer and RA patients Risk of cancer in Turkish patients after treatment with TNF antagonists Treatment response to a second or third TNF-inhibitor in RA: results from the South Swedish Arthritis Treatment Group Register Venous thromboembolism in ANCA-associated vasculitis—incidence and risk factors Involvement of TWEAK/Fn14 interaction in the synovial inflammation of RA Is Inhibitor of differentiation 3 involved in human primary Sjögren's syndrome? Comment on: An allograft inflammatory factor 1 (AIF1) single nucleotide polymorphism (SNP) is associated with anticentromere antibody positive systemic sclerosis: reply Predictors of response to anti-TNF therapy according to ACR and EULAR criteria in patients with established RA: results from the South Swedish Arthritis Treatment Group Register A survey of rheumatology nurse specialists providing telephone helpline advice within England and Wales Successful treatment of resistant scleroderma-associated interstitial lung disease with rituximab Long-term experience of bosentan for treating ulcers and healed ulcers in systemic sclerosis patients Is intimal hyperplasia a marker of neuro-ophthalmic complications of giant cell arteritis? Comment on: The candidate lupus susceptibility gene Ifi202a is largely dispensable for B-cell function Anakinra treatment for systemic onset juvenile idiopathic arthritis (SOJIA) Comment on: The pharmacogenetics of methotrexate: reply Serum leptin and ghrelin correlate with disease activity in ANCA-associated vasculitis Co-prescribing of proton pump inhibitors among chronic users of NSAIDs in the UK Promoter activity of A/G at position −168 in the type III promoter of MHCIITA gene Extracorporeal shockwave therapy shows regeneration in hip necrosis Evaluation of renal vascular lesions using circulating endothelial cells in patients with lupus nephritis Prevalence of angina, myocardial infarction and intermittent claudication assessed by Rose Questionnaire among patients with Behcet's syndrome Comment on: The pharmacogenetics of methotrexate Influence of biologic therapy on return to work in people with work disability due to ankylosing spondylitis New resting energy expenditure prediction equations for patients with rheumatoid arthritis Elevation of alkaline phosphatase in a pregnant patient with antiphospholipid syndrome: HELLP syndrome or not? Low disease activity state with corticosteroid may not represent ‘true’ low disease activity state in patients with rheumatoid arthritis

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata